Literature DB >> 24072170

Persister populations of Mycobacterium tuberculosis in sputum that grow in liquid but not on solid culture media.

Jasvir Dhillon1, P Bernard Fourie, Denis A Mitchison.   

Abstract

OBJECTIVES: Can the characteristics of persisters in cultures of Mycobacterium tuberculosis also be found in bacilli from the sputum of pulmonary tuberculosis patients? The objective of this study was to explore whether the ability of persisters to grow in liquid but not on solid culture media, as in 100 day static cultures, can also be found in bacilli in sputum.
METHODS: Serial dilutions of homogenized sputum obtained from patients before or during the first week of treatment were inoculated into broths to estimate the probable number of organisms and onto plates to give colony counts.
RESULTS: Cultures in broths grew slowly to reach a maximal count at 12 weeks of probable numbers about 10-fold higher than the colony counts on plates, which did not grow beyond the initial count at 3-4 weeks. No such excess growth in liquid medium was found with control log-phase cultures.
CONCLUSIONS: About 90% of the bacilli in sputum are persisters that can grow in liquid media but not on solid plates.

Entities:  

Keywords:  persister life cycle; persisters in sputum; therapy speed

Mesh:

Substances:

Year:  2013        PMID: 24072170     DOI: 10.1093/jac/dkt357

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  22 in total

1.  The in vivo environment accelerates generation of resuscitation-promoting factor-dependent mycobacteria.

Authors:  Obolbek Turapov; Sarah Glenn; Bavesh Kana; Vadim Makarov; Peter W Andrew; Galina V Mukamolova
Journal:  Am J Respir Crit Care Med       Date:  2014-12-15       Impact factor: 21.405

2.  Modeling and Simulation of Pretomanid Pharmacodynamics in Pulmonary Tuberculosis Patients.

Authors:  Michael A Lyons
Journal:  Antimicrob Agents Chemother       Date:  2019-09-30       Impact factor: 5.191

3.  Mycobacterium tuberculosis programs mesenchymal stem cells to establish dormancy and persistence.

Authors:  Samreen Fatima; Shashank Shivaji Kamble; Ved Prakash Dwivedi; Debapriya Bhattacharya; Santosh Kumar; Anand Ranganathan; Luc Van Kaer; Sujata Mohanty; Gobardhan Das
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

Review 4.  Clinical Aspects of Adult Tuberculosis.

Authors:  Robert Loddenkemper; Marc Lipman; Alimuddin Zumla
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-06       Impact factor: 6.915

5.  Oxidative damage and delayed replication allow viable Mycobacterium tuberculosis to go undetected.

Authors:  Kohta Saito; Saurabh Mishra; Thulasi Warrier; Nico Cicchetti; Jianjie Mi; Elaina Weber; Xiuju Jiang; Julia Roberts; Alexandre Gouzy; Ellen Kaplan; Christopher D Brown; Ben Gold; Carl Nathan
Journal:  Sci Transl Med       Date:  2021-11-24       Impact factor: 19.319

6.  Detection and Quantification of Differentially Culturable Tubercle Bacteria in Sputum from Patients with Tuberculosis.

Authors:  Melissa D Chengalroyen; Germar M Beukes; Bhavna G Gordhan; Elizabeth M Streicher; Gavin Churchyard; Richard Hafner; Robin Warren; Kennedy Otwombe; Neil Martinson; Bavesh D Kana
Journal:  Am J Respir Crit Care Med       Date:  2016-12-15       Impact factor: 21.405

7.  Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy.

Authors:  Isobella Honeyborne; Timothy D McHugh; Iitu Kuittinen; Anna Cichonska; Dimitrios Evangelopoulos; Katharina Ronacher; Paul D van Helden; Stephen H Gillespie; Delmiro Fernandez-Reyes; Gerhard Walzl; Juho Rousu; Philip D Butcher; Simon J Waddell
Journal:  BMC Med       Date:  2016-04-07       Impact factor: 8.775

8.  Characterization of Differentially Detectable Mycobacterium tuberculosis in the Sputum of Subjects with Drug-Sensitive or Drug-Resistant Tuberculosis before and after Two Months of Therapy.

Authors:  Carl Nathan; Daniel W Fitzgerald; Kayvan Zainabadi; Kathleen Frances Walsh; Stalz Charles Vilbrun; Laurent Daniel Mathurin; Myung Hee Lee; Kohta Saito; Saurabh Mishra; Oksana Ocheretina; Jean William Pape
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.938

9.  Phenotypically Adapted Mycobacterium tuberculosis Populations from Sputum Are Tolerant to First-Line Drugs.

Authors:  Obolbek Turapov; Benjamin D O'Connor; Asel A Sarybaeva; Caroline Williams; Hemu Patel; Abdullaat S Kadyrov; Akpay S Sarybaev; Gerrit Woltmann; Michael R Barer; Galina V Mukamolova
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

10.  Application of the Multistate Tuberculosis Pharmacometric Model in Patients With Rifampicin-Treated Pulmonary Tuberculosis.

Authors:  R J Svensson; Ush Simonsson
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.